Table 3.
SF-36v2 Scores Before and After Ethinylestradiol/Drospirenone Treatment for Dysmenorrhea
| SF-36v2 Domain | Pre-administration (n = 186) | Post-administration (n = 186) | Change from Pre- to Post-administration |
|---|---|---|---|
| Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | |
| Physical functioning | 52.0 (50.6–53.4) | 53.4 (52.1–54.6) | 1.4 (0.5–2.2) |
| Role physical | 46.9 (45.5–48.3) | 50.1 (49.0–51.3) | 3.2 (2.1–4.4) |
| Bodily pain | 41.1 (39.4–42.8) | 48.9 (47.4–50.4) | 7.8 (6.4–9.3) |
| General health† | 49.0 (47.6–50.3) | 52.0 (50.7–53.3) | 3.0 (2.0–4.0) |
| Vitality | 46.4 (44.9–47.9) | 49.1 (47.9–50.4) | 2.7 (1.5–3.9) |
| Social functioning | 46.1 (44.7–47.5) | 49.6 (48.3–51.0) | 3.5 (2.1–4.9) |
| Role emotional | 46.0 (44.4–47.5) | 49.2 (47.9–50.6) | 3.3 (2.0–4.6) |
| Mental health | 45.5 (44.1–46.9) | 48.5 (47.2–49.8) | 3.0 (1.9–4.0) |
| Physical component summary† | 48.4 (46.9–49.8) | 51.6 (50.3–52.9) | 3.3 (2.3–4.3) |
| Mental component summary† | 45.2 (43.9–46.5) | 48.6 (47.4–49.9) | 3.4 (2.4–4.4) |
Notes: Pre-administration results were collected prior to beginning treatment; post-administration results were collected between the first day of 6th cycle and the last day of 8th menstrual cycle. †The number of patients with pre-administration scores was 184.
Abbreviations: CI, confidence interval; SF-36v2, 36-Item Short-Form Health Survey version 2.0.